Although the revenue and EPS for Bausch (BHC) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street est
Bausch Health (BHC) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.89 per share. This compares to earnings of $0.81 per share a year ago.
Second quarter consolidated revenues of $2.40 billion, up 11% on a Reported and 8% on an Organic (non-GAAP)1 basis Consolidated GAAP Net Income Attributable to Bausch Health Companies Inc. of $10 mill
Brent Saunders, Bausch + Lomb chairman and CEO, joins ‘Squawk on the Street' to discuss why the eye care segment is doing better, how under-treated dry eyes are, and where the company's growth will
Brent Saunders, Bausch + Lomb chairman and CEO, joins 'Squawk on the Street' to discuss why the eye care segment is doing better, how under-treated dry eyes are, and where the company's growth will co
Bausch (BHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 Red Alerts On Bausch Health Companies

07:00am, Thursday, 25'th Jul 2024
Rumors circulated on a pre-packaged bankruptcy filing, which Bausch Health Companies quickly refuted. Bausch Health stock previously plummeted after posting Q1 results. BHC's cash flow remains weak, w
It was quite a day for shares of Bausch Health Cos. (BHC), which were cut nearly in half before recovering as it addressed a research firm's report saying it was mulling bankruptcy options.
Specialty pharmaceutical and medical device firm Bausch Health (NYSE: BHC ) saw its shares tumble badly on Wednesday. Driving the negativity was a report by Reorg — billed as a global provider of cr

Bausch Health denies report of bankruptcy filing

01:07pm, Wednesday, 24'th Jul 2024
Bausch Health said on Wednesday it was not considering a bankruptcy or insolvency proceeding of any kind.

Bausch Health Responds to Market Rumors

12:50pm, Wednesday, 24'th Jul 2024
LAVAL, QC / ACCESSWIRE / July 24, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") has become aware of a news article issued by Reorg® today, citing unnamed sources. The articl
Shares of Bausch Health Companies Inc. BHC, -21.60% have been halted for news, with the last trade at a 14-month low. The Canada-based drug and medical devices company's stock was down 21.6% when it w
LAVAL, QC / ACCESSWIRE / July 19, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) today announced the appointment of two new members to its Executive Leadership Team (ELT). Jean-Jacques Charho
LAVAL, QC / ACCESSWIRE / July 11, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2024 financial results on Thursday, August 1, 2024. Bausch Health will host a conf
LAVAL, QC / ACCESSWIRE / June 20, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company") and its gastroenterology business, Salix Pharmaceuticals, today announced t
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE